Nanoparticulate RNA delivery systems in cancer

Author:

Sharma Ankur1ORCID,Jha Niraj Kumar2ORCID,Dahiya Kajal1,Singh Vivek Kumar2,Chaurasiya Kundan2,Jha Aditya Narayan2,Jha Saurabh Kumar2,Mishra Prabhu Chandra3,Dholpuria Sunny1,Astya Rani2,Nand Parma2,Kumar Amit4,Ruokolainen Janne5,Kesari Kavindra Kumar5

Affiliation:

1. Department of Life Science, School of Basic Science & Research Sharda University Greater Noida India

2. Department of Biotechnology, School of Engineering & Technology Sharda University Greater Noida India

3. Department of Regenerative Medicine & Cellular Therapy StemMax Research & Therapeutics Pvt Ltd. New Delhi India

4. Department of Zoology, Ram Krishna College Lalit Narayan Mithila University Darbhanga India

5. Department of Applied Physics Aalto University Espoo Finland

Publisher

Wiley

Subject

Cancer Research,Oncology

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA;Cell Biochemistry and Biophysics;2024-07-10

2. Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy;International Journal of Nanomedicine;2024-05

3. Chitosan nanocarriers for non-coding RNA therapeutics: A review;International Journal of Biological Macromolecules;2024-04

4. Nanoparticles as Gene Vectors in Tumor Therapy;Integration of Biomaterials for Gene Therapy;2023-10-05

5. Nucleic Acids in Cancer Diagnosis and Therapy;Cancers;2023-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3